ENGLISH DB 3-English homework Assignment

So far in our course, we have discussed academic writing in depth, and with this unit, you have written (or are currently writing) your first essay. How do you feel about your progress? Do you feel that you are mastering the skills of academic writing? To that end, how do you feel about your essay? Did you discover anything by going through the process of writing the essay? Is there anything that you would like to share with your course mates? Of course, not all comparative exercises are successful. Do you feel that yours was? Did you learn something, or do you feel that you may have even taught the reader something? Reflect upon your experience so far in the course.

The post ENGLISH DB 3-English homework Assignment appeared first on graduatepaperhelp.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Discuss and write about two of the most creative/successful social media

marketing campaigns in Saudi Arabia. Give the reasons behind their success?

1. Provide an example of two social media marketing campaign in Saudi Arabia

that failed. Why did the social media marketing campaign fail? And what can

we learn from them?

Note:

For each case, provide the following information:

• Company Name, Campaign Name and Social media platforms used

Examples can be a profit or non-profit organization

Assignment Guidelines:

This assignment is an individual assignment.

All students are encouraged to use their own word.

Your Assignment must include:

A cover page that contains the following:

• Student name and number.
• CRN.

Use font Times New Roman, Calibri or Arial.

Use 1.5 or double line spacing with left Justify all paragraphs.

Use the footer function to insert page number.

Ensure that you follow the APA style in your project.

Your report length should be between 500 to 700 words.

Please follow the Assignment Guidelines:

All students are encouraged to use their own word.

Student must apply any recognized Academic Referencing Style within their reports.

A mark of zero will be given for any submission that includes copying from other resource without referencing it.

No late assignments will be accepted

Citations:

Any information that you use in your project that has been derived from a published source (including our textbook) must be properly cited.

The post Discuss and write about two of the most creative/successful social media appeared first on graduatepaperhelp.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Answer the Two Peer, Apa Format Maximum 100 Word

Sonia,

Asthma is a frequent health problem in children. It is chronic. There are more than 3 million cases per year in the USA. It can be a minor problem or it can interfere with daily activities. In some cases can be life-threatening. As adults get older the illness can decrease in frequency and severity. We need to instruct our patients that certain foods can trigger asthma symptoms, for example milk, eggs, shellfish, peanuts, soy, and wheat might be responsible. Children with asthma should have a humidifier in their rooms, avoid sleeping with pets, avoid dust, and avoid dust mites, that can get in sheets and pillows.

We need to tell the parents as well as the child to try to always have inhalers available. The most common are beta agonist, which give quick bronchodilatation, also useful are steroids and leukotrine modifiers.

We as nurse practitioners are in a unique place to give appropriate health care advice, by instructing the patient and their parents or caregivers what to avoid in the environment and the diet, and what things would be beneficial. On of the most common question is what foods to avoid and which ones to use. All exercises are useful but never to over do it. Some individuals can have an attack trigger by vigorous exercise. Also avoid changes in temperatures,because it is well known that bronchospasm occurs in colder temperatures.

In my personal experience I had a 5 year old that developed attacks of difficulty breathing, which was treated successfully in the emergency room on several occasions, when we got involved with the family, we were able to obtain an extensive history, including the fact that they had recently moved to a new house, which turned out to have lot of mold, when this was addressed then the frequency and severity of the attacks diminished.

Reference:

Stucky, B. D., Sherbourne, C. D., Edelen, M. O., & Eberhart, N. K. (2015). Understanding asthma-specific quality of life: moving beyond asthma symptoms and severity. The European respiratory journal, 46(3), 680-7.

Van Aalderen W. M. (2012). Childhood asthma: diagnosis and treatment. Scientifica, 2012, 674204.

Lisette,

NAME: E.B AGE: 50 y/o SEX: male

SUBJECTIVE INFORMATION

CHIEF COMPLAINT : ”I have cough and expectoration every morning for month”

HISTORY OF PRESENT ILLNESS:

Pt is a 50 y/o hispanic male with past medical history of infertility for which it was studied years ago and was diagnosed with α1 antitrypsin deficiency, non-smoker who comes with a chief complaint of cough and morning sputum for month. The espectoria is abundant and smells of wet plaster, thick. Also in these last days he has presented fever of 102 F and the cough has become constant and annoying and sputum more green and abundant.

PAST MEDICAL HISTORY: α1 antitrypsin deficiency

IMMUNIZATIONS:

Vaccine updated

ALLERGIES: to Dust, type of reaction: runny noise.

CURRENT MEDICATION: Vitamin C PO 500 mg daily.

FAMILY HISTORY:

Mother: Bronchial Asthma

Father: CVD, PVD

SOCIAL HISTORY:

Denies illicit drugs, or drink alcohol.

MARITAL STATUS: married without child for infertility

REVIEW OF SYSTEMS

• RESPIRATORY: Productive cough and smelly expectoration with a smell of wet plaster

OBJECTIVE INFORMATION

VITALS SIGNS: Blood Pressure: 110/65 Pulse: 60 bpm Respiration: 22rpm Temperature:102 F O2 saturation: 93% at room air.

Weight: 1300 lb.

Pain level: 0/10

RESPIRATORY: Crackles and wheezing on lung auscultation. No dyspnea noted.

MUSCULOSKELETAL: Clubbing of the digits

⎫ Dieses/Condition

DIAGNOSIS: BRONCHIECTASIS WITH (ACUTE) EXACERBATION

Bronchiectasis refers to an irreversible airway dilation that involves the lung in either a focal or a diffuse manner and that classically has been categorized as cylindrical or tubular (the most common form), varicose, or cystic.

DIFFERENTIAL DIAGNOSTIC:

1- COPD

3- Strep Pneumonia

4- Tuberculosis

⎫ Population affected:

The overall reported prevalence of bronchiectasis in the United States has recently increased, but the epidemiology of bronchiectasis varies greatly with the underlying etiology. For example, patients born with CF often develop significant clinical bronchiectasis in late adolescence or early adulthood, although atypical presentations of CF in adults in their thirties and forties are also possible. In contrast, bronchiectasis resulting from MAC infection classically affects nonsmoking women >50 years of age. In general, the incidence of bronchiectasis increases with age. Bronchiectasis is more common among women than among men.

The most affected population is:

1. People that aspirated foreign body or had a tumor mass
2. People with recurrent infection (bacterial, nontuberculous mycobacterial)
3. People with Immunodeficiency (hypogammaglobulinemia, HIV infection, bronchiolitis obliterans after lung transplantation)
4. People with genetic causes (cystic fibrosis, Kartagener’s syndrome, α1 antitrypsin deficiency)
5. People that suffer from Autoimmune or rheumatologic causes (rheumatoid arthritis, Sjögren’s syndrome, inflammatory bowel disease); immune mediated disease (allergic bronchopulmonary aspergillosis)
6. Recurrent aspiration of toxics agents
7. People with α1 Antitrypsin Deficiency.

⎫ Impact on Quality of Life.

Manifestations The most common clinical presentation is a persistent productive cough with ongoing production of thick, tenacious sputum.

The aspect that most affects people with bronchiectasis are recurrent respiratory infections that can limit their quality of life due to a compromise of respiratory function.

Outcomes of bronchiectasis can vary widely with the underlying etiology and may also be influenced by the frequency of exacerbations and (in infectious cases) the specific pathogens involved. In one study, the decline of lung function in patients with non-CF bronchiectasis was similar to that in patients with COPD, with the forced expiratory volume in 1 s (FEV1) declining by 50–55 mL per year as opposed to 20–30 mL per year for healthy controls.

⎫ Current EBP that will benefit this patient with the specific disease.

Bronchiectasis doesn’t have reversibility; however, we can compensate it with an adequate therapeutic. After I have carried out a search, such as FNP, the therapeutic alternatives within our reach are the following:

1. clearance techniques: Manual techniques may be offered to enhance sputum clearance when the patient is fatigued or undergoing an exacerbation.
2. Mucoactive: Consider the use of humidification with sterile water or
3. Normal saline solution to facilitate the purification of the respiratory tract. You can also use some mucolytic mucinex.
4. Anti-inflammatory therapies: Do not routinely offer corticosteroids to patients with bronchiectasis without other indications (such as ABPA, chronic asthma, COPD and inflammatory bowel disease)
5. Antibiotic: Consider long-term antibiotics in patients with bronchiectasis who experience 3 or more exacerbations per year and in the short term in case of exacerbations. The choice of antibiotic depends on the type of patient:

P. aeruginosa colonised patients

a. Use inhaled colistin for patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.

b. Consider inhaled gentamicin as a second line alternative to colistin for patients with bronchiectasis and chronic P. aeruginosa infection.

c. Consider azithromycin or erythromycin as an alternative (eg, if a patient does not tolerate inhaled antibiotics) to an inhaled antibiotic for patients with bronchiectasis and chronic P. aeruginosa infection.

d. Consider azithromycin or erythromycin as an additive treatment to an inhaled antibiotic for patients with bronchiectasis and chronic P. aeruginosa infection who have a high exacerbation frequency.

Non- P. aeruginosa colonised patients

a. Use azithromycin or erythromycin for patient with bronchiectasis.

b. Consider inhaled gentamicin as a second line alternative to azithromycin or erythromycin.

c. Consider doxycycline as an alternative in patients intolerant of macrolides or in whom they are ineffective.

1. Bronchodilators: Use of bronchodilators in patients with bronchiectasis and co-existing COPD or asthma should follow the guideline recommendations for COPD or asthma,
2. Pulmonary rehabilitation: Offer pulmonary rehabilitation to individuals who are functionally limited by shortness of breath (Modified Medical Research Council (MMRC) Dyspnea Scale ≥ 1)

⎫ Recommendation for treatment.

In the case of this patient as FNP I indicated:

1. Tylenol PO 400 mg every 8 hours PRN
2. Azithromycin PO 500 mg daily per 3 days
3. Mucinex 1 tablets every 12 hours.
4. Follow-up with pneumology.
5. Follow-up with physiotherapeutic for specialized respiratory physiotherapy

⎫ How as the FNP caring for this patients (teaching)

As FNP I can contribute to the quality of life of the patient by educating him in avoiding the factors that trigger an exacerbation and how to control his illness

1. Educate on medication compliance.
2. Chest physiotherapy (eg, postural drainage, traditional mechanical percussion in the chest through palms in the chest hand)
3. Drink plenty of liquid
4. Reversal of an underlying immunodeficient state (e.g., by administration of gamma globulin for immunoglobulin-deficient patients) and vaccination of patients with chronic respiratory conditions (e.g., influenza and pneumococcal vaccines) can decrease the risk of recurrent infections.
5. Patients who smoke should be counseled about smoking cessation.
6. After resolution of an acute infection in patients with recurrences (e.g., ≥3 episodes per year), the use of suppressive antibiotics to minimize the microbial load and reduce the frequency of exacerbations has been proposed, although there is less consensus with regard to this approach in non-CF-associated bronchiectasis than in patients with CF-related bronchiectasis. Possible suppressive treatments include (1) administration of an oral antibiotic (e.g., ciprofloxacin) daily for 1–2 weeks per month; (2) use of a rotating schedule of oral antibiotics (to minimize the risk of development of drug resistance); (3) administration of a macrolide antibiotic (see below) daily or three times per week (with mechanisms of possible benefit related to non-antimicrobial properties, such as anti-inflammatory effects and reduction of gramnegative bacillary biofilms); (4) inhalation of aerosolized antibiotics (e.g., tobramycin inhalation solution) by select patients on a rotating schedule (e.g., 30 days on, 30 days off ), with the goal of decreasing he microbial load without eliciting the side effects of systemic drug administration; and (5) intermittent administration of IV antibiotics (e.g., “clean-outs”) for patients with more severe bronchiectasis and/or resistant pathogens.

References

1. Haworth C, Banks J, Capstick T, et al. BTS Guidelines for the management of nontuberculous mycobacterial pulmonary disease. Thorax 2017;72:1–64.
2. Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 2010;138:944–9
3. Bibby S, Milne R, Beasley R. Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand. N Z Med J 2015;128:30–8
4. Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016;47:186–93
5. van der Bruggen-Bogaarts BA, van der Bruggen HM, van Waes PF, et al. Screening for bronchiectasis. A comparative study between chest radiography and highresolution CT. Chest 1996;109:608–11.

The post Answer the Two Peer, Apa Format Maximum 100 Word appeared first on graduatepaperhelp.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Read the required sources listed in the Background Info.

An organization can do things the same way indefinitely unless it stops to think about them. The process of stopping to think, and then acting, is called process improvement. DHL finds that it’s critical in driving down costs, both for itself, and for its partners. “Within the retail and consumer group at DHL Exel Supply Chain, we’ve already held almost 100 Process Improvement/DMAIC workshops this year, which have contributed to continuous improvements and identified effectiveness equating to four million pounds sterling.”

One thing to look at is the whole value chain— the flows of goods, information and money, business systems, business structures and functional silos, corporate culture, etc. “We offer our customers these as ‘Value Chain Assessments’ (VCA), where a customer may have a broad question—where is the risk in my supply chain? Where are my major costs and how can I impact them? Answering these questions is often easier said than done as many in-company logistics or supply chain managers lack visibility beyond their own supply chain operations. We can fill in the gaps in the picture—especially with today’s highly complex and extended retail supply chains. With a wide range of clients, 3PLs can provide benchmarking and information on best practice drawn from a range of industries, as well as practical deliverable solutions. Our VCA methodology challenges our customers to embrace change—but it also challenges our own teams to do likewise. Success is not in the delivery of VCA report—it’s in being a catalyst to deliver benefits to our customers.”

Write an essay responding to the following questions.

Explain why a two-stage benchmarking methodology, which utilizes performance evaluation metrics followed by continuous improvement metrics, can be a useful tool for achieving competitive advantage.

Discuss why the inclusion of the second phase, related to continuous improvement, represents a step forward from traditional benchmarking approaches.

Evaluate the general adequacy of the major performance criteria used in the AHP article for assessing other organizations’ logistics. Feel free to suggest additions to, or modifications of, the performance criteria if you believe these are inadequate.

Describe the role a 3PL could play in implementing an effective benchmarking strategy.

Assignment Expectations

Display an in-depth understanding of benchmarking, benchmarking metrics, and how benchmarking is integrated into the strategic management effort. Display a critical assessment of the benefits and limitations of the two phases of a double Analytic Hierarchical Process approach to benchmarking. Display critical thinking, rigorous logic, and synthesis of the current course materials with previous courses to assess the relationship between the AHP approach and continuous process improvement. 

General Case Expectations

Write a well-constructed essay. Feel free to use tables and bulleted lists, if appropriate.

The readings may not provide specific answers. In that event, you will need to “fill in the gaps,” using your understanding of the material presented in the module, and the background sources.

Style and format must comply with the Writing Style Guide. (TUI Guide, n.d.) This is not an English course; however, errors in spelling, grammar and style will be penalized.

Provide citations and references. Use of APA style is encouraged, but not required. Please see the TUI Writing Guide, or visit the Purdue Online Writing Lab (OWL, 2015).

There is no page requirement. Write what you need to write, neither more nor less.

Upload your Case before the end of the module.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"